MedicineOS
Back to Search

Lesero 250 250 mg/vial

IV/IM Injection
Generic:Ceftazidime
Company:Ziska Pharmaceuticals Ltd.

Pricing Details

Unit Price৳0.00

Indications

Lesero 250 is indicated for conditions managed by Ceftazidime. Comprehensive clinical indications are currently being synced.

Pharmacology

The active ingredient Ceftazidime operates via standard pharmacokinetic and pharmacodynamic pathways. Detailed mechanism of action is pending verification.

Dosage & Administration

Please consult your registered physician before taking Lesero 250. Follow the prescribed dosage strictly based on patient age, weight, and clinical condition.

Contraindications

Hypersensitivity to Ceftazidime or any components of the formulation. Patients with severe hepatic or renal impairment should exercise caution.

Side Effects

Adverse reactions may occur. If you experience any severe or unexpected side effects, please report them to your healthcare provider immediately.

Frequently Asked Questions

What is Lesero 250 used for?

Lesero 250 contains Ceftazidime and is primarily used for the treatment of conditions related to this active ingredient.

What is the price of Lesero 250 in Bangladesh?

The current MRP of Lesero 250 is ৳0 per unit.

Are there cheaper alternatives to Lesero 250?

Currently, we could not find cheaper identical generic alternatives in our database.

Smart Alternatives

Cheaper equivalents with identically matched generic compositions.

No alternatives found.